70 Folgen

  1. Emerging Markets Collaborate to Succeed in Post-Pandemic World

    Vom: 11.4.2023

  2. Breathing Oxygen Back into the Biological Conversation

    Vom: 6.2.2023

  3. Global Single-Use Network Supports Assurance of Supply

    Vom: 30.1.2023

  4. Resins Address Downstream Purification Concerns

    Vom: 3.1.2023

  5. Materials Sourcing: Precautions and Improvements for Cell and Gene Therapies

    Vom: 1.12.2022

  6. Mechanistic Modeling Improves Drug Discovery Workflows and Speeds Therapeutic Development

    Vom: 1.12.2022

  7. Moving the Drug Pipeline Forward with Mechanistic Modeling

    Vom: 1.12.2022

  8. Reducing Drug Discovery and Development Risk with Mechanistic Modeling

    Vom: 2.5.2022

  9. Meet the Editor-in-Chief of GEN Biotechnology: Hana El-Samad, PhD

    Vom: 17.12.2021

  10. Interrogating the Links between Genetics and Psychiatric Disorders with High Throughput Assays

    Vom: 2.12.2021

  11. Navigating the Regulatory Terrain during Cell & Gene Therapy Production

    Vom: 9.6.2021

  12. Solve Your Biotherapeutic Challenges with Help from Gene Therapy University

    Vom: 5.5.2021

  13. Engineered Therapy: Ramping Up CAR-T Biomanufacturing Goals

    Vom: 11.1.2021

  14. What is so different about CRISPR Founder breeding?

    Vom: 16.12.2020

  15. Collaborating for Filtration Success, Virtually

    Vom: 2.12.2020

  16. Back to the Lab – Embracing Change

    Vom: 20.11.2020

  17. Virtual Becomes Reality for Biopharma Vaccine Development

    Vom: 29.10.2020

  18. Digital Tools Push Single-Use Technology Challenges to the Side

    Vom: 16.9.2020

  19. The Quiet Voice of Immunotherapy That's Starting to Be Heard

    Vom: 24.8.2020

  20. Virtual Collaborations Push Pharma Forward During Pandemic

    Vom: 30.7.2020

1 / 4

Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.GEN's print magazine, which also can easily be accessed online, includes feature articles on emerging technologies, product roundups, in-depth overviews from key scientific and bioindustry meetings, and industry-standard tutorials and technical articles on drug discovery, bioprocessing, and assay technologies. Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site